AGIO:NASDAQ
Agios Pharmaceuticals Inc
29,56 $
arrow_downward
-1,96%(-0,59) 1D
17 նոյ, 13:47:57 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
30,09 $
High
30,38 $
Low
28,94 $
Mkt. cap
1,77 մլրդ
Avg. vol.
1,23 մլն
Volume
244,21 հզր
52-wk high
45,99 $
52-wk low
22,24 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
Open
30,09 $
High
30,38 $
Low
28,94 $
Mkt. cap
1,77 մլրդ
Avg. vol.
1,23 մլն
Volume
244,21 հզր
52-wk high
45,99 $
52-wk low
22,24 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
News stories
From web sources and news partners
ChartMill
·
1 ժամ առաջ
Today's S&P 500 Top Movers: Reddit Leads Gainers, Salesforce Leads Decliners
MarketWatch
·
1 ժամ առաջ
Why Salesforce’s stock is leading S&P 500 decliners amid tech jitters
24/7 Wall St.
·
46 րոպե առաջ
Bill Ackman Cut His Microsoft Stake. Your S&P 500 Fund Can’t.
BigGo Finance
·
1 ժամ առաջ
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc